# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:MDNA, OTC:MDNAF), a clinical-stage immunothera...
Company's T-MASK platform demonstrates ability to maximize anti-tumor efficacy and minimize systemic toxicity, and opportun...
Gainers
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Friday. Following the...
New data from the Phase 1 dose-escalation and evaluation portion of the trial will be presented at the Society of Immunotherapy...
Friday's session saw 112 companies set new 52-week lows.